查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1958435

远端患者监护人工智慧市场（至2040年）：依组件、应用、最终用户和主要地区划分的行业趋势和全球预测

Artificial Intelligence (AI) in Remote Patient Monitoring Market, till 2040: Distribution by Type of Component, Application Area, Type of End-User, and Key Geographical Regions: Industry Trends and Global Forecasts
出版日期: | 出版商: Roots Analysis | 英文 176 Pages | 商品交期: 7-10个工作天内

价格
简介目录

全球远距病患监护人工智慧市场预计将从目前的33.5亿美元成长到2040年的614亿美元，预测期内年复合成长率（CAGR）为 23.1%。

远距病患监护（RPM）中的人工智慧革新医疗保健，它利用人工智慧在传统临床环境之外追踪和分析病患的健康资料。穿戴式装置、感测器和行动应用程式从居家或远端地点的患者收集即时生命体征，例如心率、血压、血氧饱和度和活动模式。基于机器学习的人工智慧演算法处理这些海量资料流，检测异常情况，预测潜在的健康状况（例如心臟衰竭），并为临床医生产生可操作的警报。

这种预防性方法能够实现早期干预，有助于降低医院再入院率。关键技术包括用于风险分层的预测分析、用于解读患者报告结果的自然语言处理以及用于远端伤口评估的电脑视觉。此外，这些工具透过个人化提醒和在老龄化社会中提供可扩展的护理，有助于提高患者的用药依从性。儘管面临资料隐私和演算法偏差等挑战，但预计远距患者监护人工智慧市场在预测期内将快速成长。

Artificial Intelligence (AI) in Remote Patient Monitoring Market-IMG1

人工智慧对提高用药依从性的影响

用药依从性差是医疗保健领域的一大障碍，会降低治疗效果并增加成本。将人工智慧整合到远端患者监护中，透过个人化介入和持续监测，为提高用药依从性提供了一种变革性的解决方案。人工智慧利用先进的行为分析技术，透过演算法分析患者的用药模式并预测潜在的漏服剂量，提高患者的用药依从性。个人化的提醒会根据个人的日程安排和偏好进行定制，并透过定向通知推送，以促进患者及时服药。

此外，人工智慧透过汇总来自电子健康记录（EHR）和穿戴式装置的资料，实现对用药依从性的即时监测，并为患者和医疗保健提供者提供即时回馈。此外，人工智慧还透过解释用药依从性的益处、纠正常见的误解以及提供教育资源来促进患者的参与，鼓励患者养成持久的行为习惯。

人工智慧在远端病患监测领域取得的重大技术进展

远端患者监测（RPM）技术的进步透过智慧穿戴装置和感测器革新医疗保健，这些装置和感测器可以追踪多种因素，包括心率、血糖水准、紫外线照射和汗液分析。利用机器学习模型进行预测分析，分析来自物联网整合系统的持续趋势，以预测心臟病发作和再次入院等关键事件，实现主动式个人化护理。 生成式人工智慧和自然语言处理技术，包括大规模语言模型，简化了非结构化资料处理并实现了临床记录的自动化，减轻了医护人员的负担。人工智慧驱动的虚拟助理提供个人化的用药提醒、病患教育和心理健康支持，促进病患参与，并将医疗保健从被动回应转变为主动预测。这些创新最终将改善慢性病管理、早期检测、效率和远距医疗效果。这些技术突破有望推动市场显着扩张，并重新定义医疗保健服务标准。

远距病患监护人工智慧市场：主要市场细分

元件

  • 设备
  • 软体
  • 服务

应用

  • 心血管疾病
  • 健康促进
  • 糖尿病管理
  • 呼吸监测
  • 其他

最终使用者

  • 医疗服务提供者
  • 诊断中心
  • 家庭医疗保健服务提供者
  • 製药和生技公司
  • 其他

地区

  • 北美
  • 美国
  • 加拿大
  • 墨西哥
  • 其他北美地区国家
  • 欧洲
  • 奥地利
  • 比利时
  • 丹麦
  • 法国
  • 德国
  • 义大利
  • 荷兰
  • 挪威
  • 俄罗斯
  • 西班牙
  • 瑞典
  • 瑞士
  • 英国
  • 其他欧洲国家
  • 亚洲
  • 中国
  • 印度
  • 日本
  • 新加坡
  • 韩国
  • 其他亚洲国家
  • 拉丁美洲
  • 巴西
  • 智利
  • 哥伦比亚
  • 委内瑞拉
  • 其他拉丁美洲国家
  • 中东和北非非洲
  • 埃及
  • 伊朗
  • 伊拉克
  • 以色列
  • 科威特
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 其他中东和北非国家
  • 世界其他地区

本报告分析了全球远距病患监护人工智慧市场，并提供了市场概况、背景、市场影响因素分析、市场规模趋势和预测、按不同细分市场和地区进行的详细分析、竞争格局以及主要公司的简介。

目录

第一部分：报告概述

第1章 引言

第2章 研究方法

第3章 市场动态

第4章 宏观经济指标

第二部分：定性洞察

第5章 执行摘要

第6章 引言

第7章 监理环境

第三部分：市场概览

第8章 主要公司综合资料库

第9章 竞争格局

第10章 空白分析

第11章 竞争分析

第12章 人工智慧远距病患监护市场的新创生态系统

第四部分：公司简介

第13章 公司简介

  • 章节概述
  • Abbott
  • BioIntelliSense
  • CompuGroup Medical
  • Dexcom
  • GE HealthCare
  • HealthSnap
  • Idoven
  • Jorie Healthcare Partners
  • Kakao Healthcare
  • Lepu Medical
  • Masimo
  • Medtronic
  • OMRON Healthcare
  • ResMed
  • Roche

第五部分：市场趋势

第14章 大趋势分析

第15章 专利分析

第16章 最新进展

第六部分：市场机会分析

第16章 全球远距病患监护人工智慧市场

第17章 依组件划分的市场机会

第18章 市场机会应用

第19章 北美远距病患监护人工智慧市场机会

第20章 欧洲远距病患监护人工智慧市场机会

第21章 亚洲远距病患监护人工智慧市场机会

第22章 中东及北非远距病患监护人工智慧市场机会

第23章 拉丁美洲远距病患监护人工智慧市场机会

第24章 世界其他地区远距病患监护人工智慧市场机会

第25章 市场集中度分析：主要参与者分布

第26章 邻近市场分析

第七部分：策略工具

第27章 关键制胜策略

第28章 波特五力分析

第29章 SWOT分析

第30章 ROOTS策略建议

第八部分：其他独家见解

第31章 来自一手研究的见解

第32章 报告结论

第九部分：附录

第33章 表格资料

第34章 公司列表与组织机构

第35章 ROOTS订阅服务

第36章 作者详情

简介目录
Product Code: RAD00034

AI in Remote Patient Monitoring Market Outlook

As per Roots Analysis, the global AI in remote patient monitoring market size is estimated to grow from USD 3.35 billion in current year to USD 61.40 billion by 2040, at a CAGR of 23.1% during the forecast period, till 2040.

AI in remote patient monitoring (RPM) revolutionizes healthcare by leveraging artificial intelligence to track and analyze patient health data outside traditional clinical settings. Wearable devices, sensors, and mobile apps collect real-time vital signs like heart rate, blood pressure, oxygen levels, and activity patterns from patients at home or remotely. AI algorithms, powered by machine learning, process this vast data stream to detect anomalies, predict potential health deteriorations, such as heart failure and generate actionable alerts for physicians.

This proactive approach enables early interventions and helps in reducing hospital readmissions. Key technologies include predictive analytics for risk stratification, natural language processing to interpret patient-reported outcomes, and computer vision for remote wound assessments. Additionally, such tools are beneficial for improved patient adherence through personalized nudges, and scalable care for aging populations. Despite challenges like data privacy and algorithm bias, artificial intelligence in remote patient monitoring market is projected to grow rapidly during the forecast period.

Artificial Intelligence (AI) in Remote Patient Monitoring Market - IMG1

Strategic Insights for Senior Leaders

Impact of Artificial Intelligence on Enhanced Medication Adherence

Non-adherence to medications represents a significant barrier in healthcare, compromising treatment efficacy and escalating costs. The integration of artificial intelligence (AI) into remote patient monitoring offers a transformative solution by improving adherence through tailored interventions and continuous oversight. AI enhances medication adherence via advanced behavioral analytics, employing algorithms to examine patient engagement patterns and predict potential missed doses. Personalized reminders are customized to individual schedules and preferences, delivered through targeted notifications to promote timely medication intake.

Further, by aggregating data from electronic health records (EHRs) and wearable devices, AI enables real-time adherence monitoring, providing immediate feedback to both patients and healthcare providers. Additionally, AI drives patient engagement by delivering educational resources that elucidate the benefits of adherence, address common misconceptions, and foster sustained behavioral modifications.

Key Technological Breakthroughs in AI-Enabled Remote Patient Monitoring

Advancements in remote patient monitoring (RPM) are revolutionizing healthcare through smarter wearables and sensors that track multiple aspects, such as heart rate, glucose, UV exposure, and sweat analysis. Predictive analytics powered by machine learning models analyze continuous data trends from IoT-integrated systems to forecast critical events, (such as cardiac incidents or hospital readmissions) enabling proactive, personalized interventions.

Generative AI and natural language processing, including large language models, streamline unstructured data processing for automated clinical documentation, thereby reducing clinician burnout. AI-driven virtual assistants deliver tailored medication reminders, patient education, and mental health support to boost patient engagement and shift care from reactive to predictive paradigms. These innovations ultimately improve chronic disease management, early detection, efficiency, and telehealth outcomes. These technological breakthroughs are poised to drive substantial market expansion and redefine healthcare delivery standards.

Key Drivers Propelling Growth of AI in Remote Patient Monitoring Market

The AI in remote patient monitoring (RPM) market is experiencing robust growth, propelled by several key drivers. Primarily, the rising prevalence of chronic diseases, coupled with an aging global population, necessitates continuous, real-time health surveillance beyond traditional clinical settings. AI algorithms enhance RPM devices by enabling predictive analytics, early detection, and personalized interventions, significantly reducing hospital readmissions and healthcare costs.

The COVID-19 pandemic accelerated telemedicine adoption, underscoring RPM's role in minimizing physical contact while ensuring patient safety. Advancements in wearable sensors, IoT connectivity, and edge computing further empower AI-driven platforms to process vast datasets with unprecedented accuracy and speed. Collectively, these factors are propelling the growth of the overall AI in remote patient monitoring market during the forecast period.

AI in Remote Patient Monitoring Market: Competitive Landscape of Companies in this Industry

The competitive landscape of AI in remote patient monitoring sciences features a mix of big tech giants, pharma leaders, and specialized startups driving innovation in personalized medicine and enhanced medication adherence. Leading companies like Medtronic, ResMed, GE HealthCare, Roche, Dexcom, and Abbott dominate through comprehensive AI platforms enabling chronic disease oversight, predictive modeling, and seamless wearable integration. Emerging players like BioIntelliSense, Biofourmis, and AliveCor differentiate via specialized solutions in ambient monitoring, vital signs prediction, and post-acute care, often leveraging cloud ecosystems from AWS and Microsoft Azure. This ecosystem reflects intense innovation focused on real-time data processing and value-based care reimbursement.

AI in Remote Patient Monitoring Evolution: Emerging Trends in the Industry

Emerging trends in the AI-driven remote patient monitoring market highlight a shift toward hyper-personalized predictive analytics, where machine learning algorithms establish dynamic, individualized health baselines to detect deviations and forecast adverse events. Integration of wearable biosensors and IoT-enabled devices with AI platforms enables real-time data analysis, anomaly detection, and proactive interventions, for chronic conditions (cardiovascular diseases and diabetes). Additionally, advancements in cloud-based software, AI-powered virtual assistants for patient engagement, and expanding reimbursement policies are accelerating adoption of such tools.

Regional Analysis: North America to Hold the Largest Share in the Market

According to our estimates North America currently captures a significant share of the AI in remote patient monitoring market. This can be attributed to its advanced healthcare infrastructure, high adoption of digital health technologies, and substantial investments in AI innovation. The region benefits from a high prevalence of chronic diseases, alongside favorable reimbursement policies from Medicare and private insurers that incentivize RPM deployment. Moreover, leading tech giants and healthcare providers, including those in the US and Canada, are also accelerating AI integration through partnerships and research and development initiatives.

AI in Remote Patient Monitoring Market: Key Market Segmentation

Type of Component

  • Devices
  • Software
  • Services

Application Area

  • Cardiovascular Disorders
  • Wellness Improvement
  • Diabetes Management
  • Respiratory Monitoring
  • Others

Type of End-User

  • Healthcare Providers
  • Diagnostic Centers
  • Home Healthcare Providers
  • Pharmaceutical & Biotechnology Companies
  • Others

Geographical Regions

  • North America
  • US
  • Canada
  • Mexico
  • Other North American countries
  • Europe
  • Austria
  • Belgium
  • Denmark
  • France
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Russia
  • Spain
  • Sweden
  • Switzerland
  • UK
  • Other European countries
  • Asia
  • China
  • India
  • Japan
  • Singapore
  • South Korea
  • Other Asian countries
  • Latin America
  • Brazil
  • Chile
  • Colombia
  • Venezuela
  • Other Latin American countries
  • Middle East and North Africa
  • Egypt
  • Iran
  • Iraq
  • Israel
  • Kuwait
  • Saudi Arabia
  • UAE
  • Other MENA countries
  • Rest of the World

Example Players in AI in Remote Patient Monitoring Market

  • Abbott
  • BioIntelliSense
  • CompuGroup Medical
  • Dexcom
  • GE HealthCare
  • HealthSnap
  • Idoven
  • Jorie Healthcare Partners
  • Kakao Healthcare
  • Lepu Medical
  • Masimo
  • Medtronic
  • OMRON Healthcare
  • ResMed
  • Roche

AI in Remote Patient Monitoring Market: Report Coverage

The report on the AI in remote patient monitoring market features insights on various sections, including:

  • Market Sizing and Opportunity Analysis: An in-depth analysis of the AI in remote patient monitoring market, focusing on key market segments, including [A] type of component, [B] application area, [C] type of end-user, and [D] key geographical regions.
  • Competitive Landscape: A comprehensive analysis of the companies engaged in the AI in remote patient monitoring market, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters and [D] ownership structure.
  • Company Profiles: Elaborate profiles of prominent players engaged in the AI in remote patient monitoring market, providing details on [A] location of headquarters, [B] company size, [C] company mission, [D] company footprint, [E] management team, [F] contact details, [G] financial information, [H] operating business segments, [I] product / technology portfolio, [J] recent developments, and an informed future outlook.
  • Megatrends: An evaluation of ongoing megatrends in the AI in remote patient monitoring industry.
  • Recent Developments: An overview of the recent developments made in the AI in remote patient monitoring market, along with analysis based on relevant parameters, including [A] year of initiative, [B] type of initiative, [C] geographical distribution and [D] most active players.
  • SWOT Analysis: An insightful SWOT framework, highlighting the strengths, weaknesses, opportunities and threats in the domain. Additionally, it provides Harvey ball analysis, highlighting the relative impact of each SWOT parameter.

Key Questions Answered in this Report

  • What is the current and future market size?
  • Who are the leading companies in this market?
  • What are the growth drivers that are likely to influence the evolution of this market?
  • What are the key partnership and funding trends shaping this industry?
  • Which region is likely to grow at higher CAGR till 2040?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

  • Detailed Market Analysis: The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • In-depth Analysis of Trends: Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. Each report maps ecosystem activity across partnerships, funding, and patent landscapes to reveal growth hotspots and white spaces in the industry.
  • Opinion of Industry Experts: The report features extensive interviews and surveys with key opinion leaders and industry experts to validate market trends mentioned in the report.
  • Decision-ready Deliverables: The report offers stakeholders with strategic frameworks (Porter's Five Forces, value chain, SWOT), and complimentary Excel / slide packs with customization support.

Additional Benefits

  • Complimentary Dynamic Excel Dashboards for Analytical Modules
  • Exclusive 15% Free Content Customization
  • Personalized Interactive Report Walkthrough with Our Expert Research Team
  • Free Report Updates for Versions Older than 6-12 Months

TABLE OF CONTENTS

SECTION I: REPORT OVERVIEW

1. PREFACE

  • 1.1. Introduction
  • 1.2. Market Share Insights
  • 1.3. Key Market Insights
  • 1.4. Report Coverage
  • 1.5. Key Questions Answered
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Database Building
    • 2.3.1. Data Collection
    • 2.3.2. Data Validation
    • 2.3.3. Data Analysis
  • 2.4. Project Methodology
    • 2.4.1. Secondary Research
      • 2.4.1.1. Annual Reports
      • 2.4.1.2. Academic Research Papers
      • 2.4.1.3. Company Websites
      • 2.4.1.4. Investor Presentations
      • 2.4.1.5. Regulatory Filings
      • 2.4.1.6. White Papers
      • 2.4.1.7. Industry Publications
      • 2.4.1.8. Conferences and Seminars
      • 2.4.1.9. Government Portals
      • 2.4.1.10. Media and Press Releases
      • 2.4.1.11. Newsletters
      • 2.4.1.12. Industry Databases
      • 2.4.1.13. Roots Proprietary Databases
      • 2.4.1.14. Paid Databases and Sources
      • 2.4.1.15. Social Media Portals
      • 2.4.1.16. Other Secondary Sources
    • 2.4.2. Primary Research
      • 2.4.2.1. Introduction
      • 2.4.2.2. Types
        • 2.4.2.2.1. Qualitative
        • 2.4.2.2.2. Quantitative
      • 2.4.2.3. Advantages
      • 2.4.2.4. Techniques
        • 2.4.2.4.1. Interviews
        • 2.4.2.4.2. Surveys
        • 2.4.2.4.3. Focus Groups
        • 2.4.2.4.4. Observational Research
        • 2.4.2.4.5. Social Media Interactions
      • 2.4.2.5. Stakeholders
        • 2.4.2.5.1. Company Executives (CXOs)
        • 2.4.2.5.2. Board of Directors
        • 2.4.2.5.3. Company Presidents and Vice Presidents
        • 2.4.2.5.4. Key Opinion Leaders
        • 2.4.2.5.5. Research and Development Heads
        • 2.4.2.5.6. Technical Experts
        • 2.4.2.5.7. Subject Matter Experts
        • 2.4.2.5.8. Scientists
        • 2.4.2.5.9. Doctors and Other Healthcare Providers
      • 2.4.2.6. Ethics and Integrity
        • 2.4.2.6.1. Research Ethics
        • 2.4.2.6.2. Data Integrity
    • 2.4.3. Analytical Tools and Databases

3. MARKET DYNAMICS

  • 3.1. Forecast Methodology
    • 3.1.1. Top-Down Approach
    • 3.1.2. Bottom-Up Approach
    • 3.1.3. Hybrid Approach
  • 3.2. Market Assessment Framework
    • 3.2.1. Total Addressable Market (TAM)
    • 3.2.2. Serviceable Addressable Market (SAM)
    • 3.2.3. Serviceable Obtainable Market (SOM)
    • 3.2.4. Currently Acquired Market (CAM)
  • 3.3. Forecasting Tools and Techniques
    • 3.3.1. Qualitative Forecasting
    • 3.3.2. Correlation
    • 3.3.3. Regression
    • 3.3.4. Time Series Analysis
    • 3.3.5. Extrapolation
    • 3.3.6. Convergence
    • 3.3.7. Forecast Error Analysis
    • 3.3.8. Data Visualization
    • 3.3.9. Scenario Planning
    • 3.3.10. Sensitivity Analysis
  • 3.4. Key Considerations
    • 3.4.1. Demographics
    • 3.4.2. Market Access
    • 3.4.3. Reimbursement Scenarios
    • 3.4.4. Industry Consolidation
  • 3.5. Robust Quality Control
  • 3.6. Key Market Segmentations
  • 3.7. Limitations

4. MACRO-ECONOMIC INDICATORS

  • 4.1. Chapter Overview
  • 4.2. Market Dynamics
    • 4.2.1. Time Period
      • 4.2.1.1. Historical Trends
      • 4.2.1.2. Current and Forecasted Estimates
    • 4.2.2. Currency Coverage
      • 4.2.2.1. Overview of Major Currencies Affecting the Market
      • 4.2.2.2. Impact of Currency Fluctuations on the Industry
    • 4.2.3. Foreign Exchange Impact
      • 4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 4.2.4. Recession
      • 4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 4.2.5. Inflation
      • 4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 4.2.5.2. Potential Impact of Inflation on the Market Evolution
    • 4.2.6. Interest Rates
      • 4.2.6.1. Overview of Interest Rates and Their Impact on the Market
      • 4.2.6.2. Strategies for Managing Interest Rate Risk
    • 4.2.7. Commodity Flow Analysis
      • 4.2.7.1. Type of Commodity
      • 4.2.7.2. Origins and Destinations
      • 4.2.7.3. Values and Weights
      • 4.2.7.4. Modes of Transportation
    • 4.2.8. Global Trade Dynamics
      • 4.2.8.1. Import Scenario
      • 4.2.8.2. Export Scenario
    • 4.2.9. War Impact Analysis
      • 4.2.9.1. Russian-Ukraine War
      • 4.2.9.2. Israel-Hamas War
    • 4.2.10. COVID Impact / Related Factors
      • 4.2.10.1. Global Economic Impact
      • 4.2.10.2. Industry-specific Impact
      • 4.2.10.3. Government Response and Stimulus Measures
      • 4.2.10.4. Future Outlook and Adaptation Strategies
    • 4.2.11. Other Indicators
      • 4.2.11.1. Fiscal Policy
      • 4.2.11.2. Consumer Spending
      • 4.2.11.3. Gross Domestic Product (GDP)
      • 4.2.11.4. Employment
      • 4.2.11.5. Taxes
      • 4.2.11.6. R&D Innovation
      • 4.2.11.7. Stock Market Performance
      • 4.2.11.8. Supply Chain
      • 4.2.11.9. Cross-Border Dynamics

SECTION II: QUALITATIVE INSIGHTS

5. EXECUTIVE SUMMARY

6. INTRODUCTION

  • 6.1. Chapter Overview
  • 6.2. Overview of AI in Remote Patient Monitoring Market
    • 6.2.1. Historical Evolution
    • 6.2.2. Key Applications
    • 6.2.3. Impact on Healthcare
  • 6.3. Future Perspective

7. REGULATORY SCENARIO

SECTION III: MARKET OVERVIEW

8. COMPREHENSIVE DATABASE OF LEADING PLAYERS

9. COMPETITIVE LANDSCAPE

  • 9.1. Chapter Overview
  • 9.2. AI in Remote Patient Monitoring Market: Overall Market Landscape
    • 9.2.1. Analysis by Year of Establishment
    • 9.2.2. Analysis by Company Size
    • 9.2.3. Analysis by Location of Headquarters
    • 9.2.4. Analysis by Ownership Structure

10. COMPANY COMPETITIVENESS ANALYSIS

11. STARTUP ECOSYSTEM IN THE AI IN REMOTE PATIENT MONITORING MARKET

  • 11.1. AI in Remote Patient Monitoring Market: Market Landscape of Startups
    • 11.1.1. Analysis by Year of Establishment
    • 11.1.2. Analysis by Company Size
    • 11.1.3. Analysis by Company Size and Year of Establishment
    • 11.1.4. Analysis by Location of Headquarters
    • 11.1.5. Analysis by Company Size and Location of Headquarters
    • 11.1.6. Analysis by Ownership Structure
  • 11.2. Key Findings

SECTION IV: COMPANY PROFILES

12. COMPANY PROFILES

  • 12.1. Chapter Overview
  • 12.2. Abbott*
    • 12.2.1. Company Overview
    • 12.2.2. Company Mission
    • 12.2.3. Company Footprint
    • 12.2.4. Management Team
    • 12.2.5. Contact Details
    • 12.2.6. Financial Performance
    • 12.2.7. Operating Business Segments
    • 12.2.8. Service / Product Portfolio (project specific)
    • 12.2.9. MOAT Analysis
    • 12.2.10. Recent Developments and Future Outlook
  • 12.3. BioIntelliSense
  • 12.4. CompuGroup Medical
  • 12.5. Dexcom
  • 12.6. GE HealthCare
  • 12.7. HealthSnap
  • 12.8. Idoven
  • 12.9. Jorie Healthcare Partners
  • 12.10. Kakao Healthcare
  • 12.11. Lepu Medical
  • 12.12. Masimo
  • 12.12. Medtronic
  • 12.14. OMRON Healthcare
  • 12.15. ResMed
  • 12.16. Roche

SECTION V: MARKET TRENDS

13. MEGA TRENDS ANALYSIS

14. PATENT ANALYSIS

15. RECENT DEVELOPMENTS

  • 15.1. Chapter Overview
  • 15.2. Recent Funding
  • 15.3. Recent Partnerships
  • 15.4. Other Recent Initiatives

SECTION VI: MARKET OPPORTUNITY ANALYSIS

16. GLOBAL AI IN REMOTE PATIENT MONITORING MARKET

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. Trends Disruption Impacting Market
  • 16.4. Demand Side Trends
  • 16.5. Supply Side Trends
  • 16.6. Global AI in Remote Patient Monitoring Market, Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 16.7. Multivariate Scenario Analysis
    • 16.7.1. Conservative Scenario
    • 16.7.2. Optimistic Scenario
  • 16.8. Investment Feasibility Index
  • 16.9. Key Market Segmentations

17. MARKET OPPORTUNITIES BASED ON TYPE OF COMPONENT

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Revenue Shift Analysis
  • 17.4. Market Movement Analysis
  • 17.5. Penetration-Growth (P-G) Matrix
  • 17.6. AI in Remote Patient Monitoring Market for Devices: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 17.7. AI in Remote Patient Monitoring Market for Software: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 17.8. AI in Remote Patient Monitoring Market for Services: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 17.9. Data Triangulation and Validation
    • 17.9.1. Secondary Sources
    • 17.9.2. Primary Sources
    • 17.9.3. Statistical Modeling

18. MARKET OPPORTUNITIES BASED ON APPLICATION AREA

  • 18.1. Chapter Overview
  • 18.2. Key Assumptions and Methodology
  • 18.3. Revenue Shift Analysis
  • 18.4. Market Movement Analysis
  • 18.5. Penetration-Growth (P-G) Matrix
  • 18.6. AI in Remote Patient Monitoring Market for Cardiovascular Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 18.7. AI in Remote Patient Monitoring Market for Diabetes Management: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 18.8. AI in Remote Patient Monitoring Market for Wellness Improvement: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 18.9. AI in Remote Patient Monitoring Market for Respiratory Monitoring: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 18.10. AI in Remote Patient Monitoring Market for Others: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 18.11. Data Triangulation and Validation
    • 18.11.1. Secondary Sources
    • 18.11.2. Primary Sources
    • 18.11.3. Statistical Modeling

19. MARKET OPPORTUNITIES FOR AI IN REMOTE PATIENT MONITORING IN NORTH AMERICA

  • 19.1. Chapter Overview
  • 19.2. Key Assumptions and Methodology
  • 19.3. Revenue Shift Analysis
  • 19.4. Market Movement Analysis
  • 19.5. Penetration-Growth (P-G) Matrix
  • 19.6. AI in Remote Patient Monitoring Market in North America: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 19.6.1. AI in Remote Patient Monitoring Market in the US: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 19.6.2. AI in Remote Patient Monitoring Market in Canada: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 19.6.3. AI in Remote Patient Monitoring Market in Mexico: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 19.6.4. AI in Remote Patient Monitoring Market in Other North American Countries: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 19.7. Data Triangulation and Validation

20. MARKET OPPORTUNITIES FOR AI IN REMOTE PATIENT MONITORING IN EUROPE

  • 20.1. Chapter Overview
  • 20.2. Key Assumptions and Methodology
  • 20.3. Revenue Shift Analysis
  • 20.4. Market Movement Analysis
  • 20.5. Penetration-Growth (P-G) Matrix
  • 20.6. AI in Remote Patient Monitoring Market in Europe: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.1. AI in Remote Patient Monitoring Market in Austria: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.2. AI in Remote Patient Monitoring Market in Belgium: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.3. AI in Remote Patient Monitoring Market in Denmark: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.4. AI in Remote Patient Monitoring Market in France: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.5. AI in Remote Patient Monitoring Market in Germany: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.6. AI in Remote Patient Monitoring Market in Ireland: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.7. AI in Remote Patient Monitoring Market in Italy: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.8. AI in Remote Patient Monitoring Market in Netherlands: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.9. AI in Remote Patient Monitoring Market in Norway: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.10. AI in Remote Patient Monitoring Market in Russia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.11. AI in Remote Patient Monitoring Market in Spain: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.12. AI in Remote Patient Monitoring Market in Sweden: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.13. AI in Remote Patient Monitoring Market in Switzerland: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.14. AI in Remote Patient Monitoring Market in the UK: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 20.6.15. AI in Remote Patient Monitoring Market in Other European Countries: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 20.7. Data Triangulation and Validation

21. MARKET OPPORTUNITIES FOR AI IN REMOTE PATIENT MONITORING IN ASIA

  • 21.1. Chapter Overview
  • 21.2. Key Assumptions and Methodology
  • 21.3. Revenue Shift Analysis
  • 21.4. Market Movement Analysis
  • 21.5. Penetration-Growth (P-G) Matrix
  • 21.6. AI in Remote Patient Monitoring Market in Asia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 21.6.1. AI in Remote Patient Monitoring Market in China: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 21.6.2. AI in Remote Patient Monitoring Market in India: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 21.6.3. AI in Remote Patient Monitoring Market in Japan: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 21.6.4. AI in Remote Patient Monitoring Market in Singapore: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 21.6.5. AI in Remote Patient Monitoring Market in South Korea: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 21.6.6. AI in Remote Patient Monitoring Market in Other Asian Countries: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 21.7. Data Triangulation and Validation

22. MARKET OPPORTUNITIES FOR AI IN REMOTE PATIENT MONITORING IN MIDDLE EAST AND NORTH AFRICA (MENA)

  • 22.1. Chapter Overview
  • 22.2. Key Assumptions and Methodology
  • 22.3. Revenue Shift Analysis
  • 22.4. Market Movement Analysis
  • 22.5. Penetration-Growth (P-G) Matrix
  • 22.6. AI in Remote Patient Monitoring Market in Middle East and North Africa (MENA): Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 22.6.1. AI in Remote Patient Monitoring Market in Egypt: Historical Trends (Since 2022) and Forecasted Estimates (Till 205)
    • 22.6.2. AI in Remote Patient Monitoring Market in Iran: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 22.6.3. AI in Remote Patient Monitoring Market in Iraq: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 22.6.4. AI in Remote Patient Monitoring Market in Israel: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 22.6.5. AI in Remote Patient Monitoring Market in Kuwait: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 22.6.6. AI in Remote Patient Monitoring Market in Saudi Arabia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 22.6.7. AI in Remote Patient Monitoring Market in United Arab Emirates (UAE): Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 22.6.8. AI in Remote Patient Monitoring Market in Other MENA Countries: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 22.7. Data Triangulation and Validation

23. MARKET OPPORTUNITIES FOR AI IN REMOTE PATIENT MONITORING IN LATIN AMERICA

  • 23.1. Chapter Overview
  • 23.2. Key Assumptions and Methodology
  • 23.3. Revenue Shift Analysis
  • 23.4. Market Movement Analysis
  • 23.5. Penetration-Growth (P-G) Matrix
  • 23.6. AI in Remote Patient Monitoring Market in Latin America: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 23.6.1. AI in Remote Patient Monitoring Market in Argentina: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 23.6.2. AI in Remote Patient Monitoring Market in Brazil: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 23.6.3. AI in Remote Patient Monitoring Market in Chile: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 23.6.4. AI in Remote Patient Monitoring Market in Colombia Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 23.6.5. AI in Remote Patient Monitoring Market in Venezuela: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 23.6.6. AI in Remote Patient Monitoring Market in Other Latin American Countries: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
  • 23.7. Data Triangulation and Validation

24. MARKET OPPORTUNITIES FOR AI IN REMOTE PATIENT MONITORING IN REST OF THE WORLD

  • 24.1. Chapter Overview
  • 24.2. Key Assumptions and Methodology
  • 24.3. Revenue Shift Analysis
  • 24.4. Market Movement Analysis
  • 24.5. Penetration-Growth (P-G) Matrix
  • 24.6. AI in Remote Patient Monitoring Market in Rest of the World: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 24.6.1. AI in Remote Patient Monitoring Market in Australia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 24.6.2. AI in Remote Patient Monitoring Market in New Zealand: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
    • 24.6.3. AI in Remote Patient Monitoring Market in Other Countries
  • 24.7. Data Triangulation and Validation

25. MARKET CONCENTRATION ANALYSIS: DISTRIBUTION BY LEADING PLAYERS

26. ADJACENT MARKET ANALYSIS

SECTION VII: STRATEGIC TOOLS

27. KEY WINNING STRATEGIES

28. PORTER'S FIVE FORCES ANALYSIS

29. SWOT ANALYSIS

30. ROOTS STRATEGIC RECOMMENDATIONS

  • 30.1. Chapter Overview
  • 30.2. Key Business-related Strategies
    • 30.2.1. Research & Development
    • 30.2.2. Product Manufacturing
    • 30.2.3. Commercialization / Go-to-Market
    • 30.2.4. Sales and Marketing
  • 30.3. Key Operations-related Strategies
    • 30.3.1. Risk Management
    • 30.3.2. Workforce
    • 30.3.3. Finance
    • 30.3.4. Others

SECTION VIII: OTHER EXCLUSIVE INSIGHTS

31. INSIGHTS FROM PRIMARY RESEARCH

32. REPORT CONCLUSION

SECTION IX: APPENDIX

33. TABULATED DATA

34. LIST OF COMPANIES AND ORGANIZATIONS

35. ROOTS SUBSCRIPTION SERVICES

36. AUTHOR DETAILS